BTK inhibition ameliorates autoimmune arthritis and treatsTLR7/IFN-driven murine lupus, while BTK-deficient XID mice show reduced severity in many inflammatory disease models such as autoimmune encephalomyelitis (EAE), colitis, and acute edema [97, 116, 117]. The gene discussed is BTK; the disease is colitis.